Jones Keith Anthony SEC Filing Summary

This filing details a transaction by Jones Keith Anthony, a director at Humacyte, Inc. On September 14, 2026, Mr. Jones acquired 10,000 shares of Common Stock at a price of $0.562 per share. Following this transaction, he holds 50,000 shares of Humacyte, Inc. stock directly.